GoodRx CEO shrugs off $5B dive following Amazon pharmacy move

Newly-listed GoodRx Holdings got caught in the crosshairs of Amazon.com's latest plans to shake up the drug industry, triggering a wipeout of about $5 billion in market value in just two days. But its chief executive officer is shrugging it off.